Page last updated: 2024-08-24

cephalosporin c and Pulmonary Disease, Chronic Obstructive

cephalosporin c has been researched along with Pulmonary Disease, Chronic Obstructive in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (44.44)29.6817
2010's5 (55.56)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukuda, Y; Fukushima, K; Harada, Y; Hashiguchi, K; Ide, S; Imamura, Y; Inoue, Y; Izumikawa, K; Kaku, N; Kobayashi, T; Kohno, S; Kondo, A; Kosai, K; Mihara, T; Miyazaki, T; Morinaga, Y; Mukae, H; Nakamura, S; Saijo, T; Sasaki, E; Sawai, T; Suyama, N; Takazono, T; Yamamoto, K; Yanagihara, K1
Griffiths, CL; Gutierrez, KC; Lovell, RD; Pitt, RD1
Blasi, F; Braido, F; Di Marco, F; Santus, P; Scichilone, N1
Bonnaure-Mallet, M; Ehrmann, E; Fosse, T; Jolivet-Gougeon, A1
Camarasa, A; Chiner, E; Sancho-Chust, JN1
Lindenauer, PK; Pekow, PS; Rothberg, MB; Shieh, MS; Stefan, MS1
Shmelev, EI1
Blum, J; Branscombe, JM; Harrow, EM; Oldenburg, FA; Rodgerson, L; Shortall, SP1

Reviews

3 review(s) available for cephalosporin c and Pulmonary Disease, Chronic Obstructive

ArticleYear
The role of cefditoren in the treatment of lower community-acquired respiratory tract infections (LRTIs): from bacterial eradication to reduced lung inflammation and epithelial damage.
    European review for medical and pharmacological sciences, 2014, Volume: 18, Issue:3

    Topics: Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Disease Eradication; Disease Progression; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pneumonia, Bacterial; Pulmonary Disease, Chronic Obstructive

2014
Multidrug-resistant oral Capnocytophaga gingivalis responsible for an acute exacerbation of chronic obstructive pulmonary disease: Case report and literature review.
    Anaerobe, 2016, Volume: 42

    Topics: Aged; Anti-Bacterial Agents; Capnocytophaga; Cephalosporins; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gene Expression; Gram-Negative Bacterial Infections; Humans; Lincosamides; Macrolides; Male; Mutation; Pulmonary Disease, Chronic Obstructive; Streptogramins

2016
[Respiratory fluoroquinolones in the treatment of exacerbations of chronic obstructive lung disease].
    Problemy tuberkuleza i boleznei legkikh, 2004, Issue:12

    Topics: Administration, Oral; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Bacteria; Cefepime; Cephalosporins; Ciprofloxacin; Clavulanic Acid; Fluoroquinolones; Humans; Injections, Intravenous; Ofloxacin; Pulmonary Disease, Chronic Obstructive; Risk Factors; Time Factors

2004

Trials

1 trial(s) available for cephalosporin c and Pulmonary Disease, Chronic Obstructive

ArticleYear
Treatment of patients hospitalized for exacerbations of chronic obstructive pulmonary disease: comparison of an oral/metered-dose inhaler regimen and an intravenous/nebulizer regimen.
    Respiratory care, 2002, Volume: 47, Issue:2

    Topics: Administration, Inhalation; Administration, Oral; Aged; Albuterol; Bronchodilator Agents; Cefuroxime; Cephalosporins; Chi-Square Distribution; Drug Administration Schedule; Drug Therapy, Combination; Female; Forced Expiratory Volume; Glucocorticoids; Hospitalization; Humans; Infusions, Intravenous; Ipratropium; Male; Methylprednisolone; Nebulizers and Vaporizers; Pulmonary Disease, Chronic Obstructive; Treatment Outcome

2002

Other Studies

5 other study(ies) available for cephalosporin c and Pulmonary Disease, Chronic Obstructive

ArticleYear
Efficacy and safety of cefditoren pivoxil for exacerbations of chronic obstructive pulmonary disease: A prospective multicenter interventional study.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2019, Volume: 25, Issue:9

    Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Antimicrobial Stewardship; Cephalosporins; Female; Humans; Male; Middle Aged; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Young Adult

2019
Eosinophilic pneumonia induced by ceftaroline.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2014, Mar-01, Volume: 71, Issue:5

    Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Ceftaroline; Cephalosporins; Drug Hypersensitivity; Female; Humans; Hypoxia; Methicillin-Resistant Staphylococcus aureus; Methylprednisolone; Penicillins; Pulmonary Disease, Chronic Obstructive; Pulmonary Eosinophilia; Staphylococcal Infections

2014
[Pulmonary abscess due to Leuconostoc species in an immunocompetent patient].
    Archivos de bronconeumologia, 2009, Volume: 45, Issue:9

    Topics: Aged; Anti-Bacterial Agents; Bronchoscopy; Cephalosporins; Cryptogenic Organizing Pneumonia; Gram-Positive Bacterial Infections; Humans; Immunocompetence; Leuconostoc; Lung Abscess; Male; Pulmonary Disease, Chronic Obstructive; Radiography

2009
Association between antibiotic treatment and outcomes in patients hospitalized with acute exacerbation of COPD treated with systemic steroids.
    Chest, 2013, Volume: 143, Issue:1

    Topics: Aged; Anti-Bacterial Agents; Cephalosporins; Cohort Studies; Disease Progression; Drug Therapy, Combination; Female; Glucocorticoids; Hospital Mortality; Humans; Macrolides; Male; Middle Aged; Multivariate Analysis; Patient Readmission; Pulmonary Disease, Chronic Obstructive; Quinolones; Retrospective Studies; Treatment Outcome

2013
[Recommendations for the management of COPD. Essential points/general medicine version].
    Presse medicale (Paris, France : 1983), 2003, Jul-26, Volume: 32, Issue:25

    Topics: Adrenal Cortex Hormones; Adult; Age Factors; Aged; Anti-Bacterial Agents; Bronchodilator Agents; Cephalosporins; Female; Hospitalization; Humans; Lung Transplantation; Male; Prevalence; Prognosis; Pulmonary Disease, Chronic Obstructive; Respiratory Function Tests; Risk Factors; Sex Factors; Smoking; Smoking Cessation; Spirometry; Time Factors

2003